South San Francisco, CA, United States of America

Nancy E Stagliano

This inventor holds 41 USPTO granted patents and 18 published patent applications, plus 6 CIPO patents and 7 EPO patents, primarily in Antibody Therapeutics. Top assignees: Cytomx Therapeutics, Inc., Ipierian, Inc., True North Therapeutics, Inc.. Active years: 2013-2025.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Nancy E Stagliano. Retrieved from https://idiyas.com/inventor/nancy-e-stagliano

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 41 (Patent Applications = 18)

% Patents Active = 87.8

CIPO Patents = 6 (Patent Applications = 7)

EPO Patents = 7 (Patent Applications = 19)

Average Co-Inventor Count = 4.6

ph-index = 19

Forward Citations = 985(Granted Patents)

Location History:

South San Francisco, CA (US) (2014 - 2019)
San Francisco, CA (US) (2015 - 2020)
Santa Barbara, CA (US) (2013 - 2021)

Company Filing History:

20 out of 94

Cytomx Therapeutics, Inc.

True North Therapeutics, Inc.

patents

4. 7 out of 16,035

University of California

where one patent can have more than one assignee

Years Active: 2013-2025

Loading Chart...

Areas of Expertise:

Anti-C1S Antibodies

Activatable Antibodies

Tauopathy Treatment

Anti-EGFR Antibodies

Complement Inhibition

Binding Polypeptides

Matrix Metalloprotease

Soluble Notch Receptors

Cleavable Peptides

Proproteins

Cross-Reactive Antibodies

Methods of Use

41 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12391750 - Anti-C1S antibodies and methods of use thereof (2025-08-19),

2. 12240917 - Anti-complement C1s antibodies and uses thereof (2025-03-04),

3. 12215169 - Anti-complement C1s antibodies and uses thereof (2025-02-04),

4. 12209120 - Activatable anti-VEGF scFv (2025-01-28),

5. 11028162 - Methods for manufacturing activatable binding polypeptides comprising matrix metalloprotease cleavable moieties (2021-06-08),

6. 10875913 - Methods of treatment using activatable anti-EGFR antibodies (2020-12-29),

7. 10513549 - Cleavage-activatable interferon-alpha proprotein (2019-12-24),

8. 10457745 - Anti-complement C1s antibodies (2019-10-29),

9. 10450382 - Anti-complement C1s antibodies (2019-10-22),

10. 10301380 - Anti-jagged 1/jagged 2 cross-reactive antibodies, activatable anti-jagged antibodies and methods of use thereof (2019-05-28),

11. 10118961 - Modified antibody containing the cleavable peptide with the amino acid sequence TGRGPSWV (2018-11-06),

12. 10077300 - Activatable binding polypeptides and methods of identification and use thereof (2018-09-18),

13. 10059762 - Anti-EGFR activatable antibodies (2018-08-28),

14. 10040847 - Methods of treating a tauopathy (2018-08-07),

15. 9777058 - Methods of treating a tauopathy (2017-10-03),

Title: The Innovative Journey of Nancy E Stagliano

Introduction: Nancy E Stagliano is a pioneering inventor based in South San Francisco, CA. She has made significant contributions to the field of biotechnology through her groundbreaking inventions and patents.

Latest Patents: Nancy E Stagliano holds several patents in the biotechnology sector, focusing on novel drug delivery systems and innovative medical devices. Her most recent patents showcase her commitment to pushing the boundaries of scientific discovery.

Career Highlights: With a career spanning over two decades, Nancy E Stagliano has established herself as a leading figure in the biotechnology industry. Her work has not only revolutionized the way we approach healthcare but has also paved the way for future innovations in the field.

Collaborations: Throughout her career, Nancy E Stagliano has collaborated with top research institutions, universities, and biotech companies to further her inventions. These collaborations have been instrumental in bringing her ideas to life and making a tangible impact on the world.

Conclusion: Nancy E Stagliano's passion for innovation and dedication to improving healthcare have solidified her reputation as a trailblazing inventor. Her work continues to inspire the next generation of inventors and researchers in the biotechnology field.

Profile summary based on public USPTO records.